Novel Triplet Yields Undetectable MRD Status in 90% of CLL/SLL Patients Zanubrutinib plus obinutuzumab and venetoclax was also well tolerated Nov 29, 2021
'Actual' 5-Year Survival Rate of 27% After Surgery, Chemo for Pancreatic Cancer Fewer than half of the survivors remained recurrence- or disease-free Nov 19, 2021
Year in Review: Prostate Cancer PSMA-targeted imaging agent approvals, MRI-targeted biopsies, and genomic testing Nov 19, 2021
FDA OKs PD-1 Inhibitor for Adjuvant Treatment of Kidney Cancer Key trial showed 32% reduction in risk of recurrence with pembrolizumab Nov 18, 2021
Ceritinib Shows Promise in ALK-Positive Pediatric Malignancies Responses seen in neuroblastoma, among other tumors Nov 17, 2021
Tumor Spill Common in Minimally Invasive Hysterectomies for Endometrial Cancer Few surgeons in survey reported changing post-op management after spillage Nov 16, 2021
Year in Review: HER2-Positive Breast Cancer ADCs impress in second-line therapy, primary surgery debate, neoadjuvant PD-L1 falls short Nov 15, 2021
Pegylated Interferon Wins FDA Approval for Polycythemia Vera Majority of patients attained complete hematologic response with ropeginterferon alfa-2b Nov 15, 2021
Chemo-ICI Combo Promising in Soft Tissue Sarcoma PFS rate of 69% at 12 weeks in liposarcoma patients with eribulin and pembrolizumab Nov 14, 2021
Active Surveillance Still the Best Bet in Desmoid-Type Fibromatosis GRAFITI trial show's less than a third of watched patients eventually need active treatment Nov 13, 2021
Just How Bad Is a 'Sulfur Microbial Diet' for Colorectal Cancer Risk? Risk for CRC increased by 27% in healthcare workers who consumed the highest amounts Nov 12, 2021
T-Cell Therapy Shows Promise in Rare Sarcomas Afami-cel induced durable responses in synovial sarcoma and myxoid/round cell liposarcoma Nov 12, 2021
Preterm Birth Drug Tied to Cancer Risk in Those Exposed in Utero Mothers who took 17-OHPC for miscarriage in the 1950s and 1960s had offspring at greater risk Nov 12, 2021
High COVID Complication Rates in Sarcoma Patients Half of patients in registry-based study were hospitalized Nov 12, 2021
Ripretinib Continues to Demonstrate Benefit in Advanced GIST Updated analysis shows stable PFS, improved OS Nov 11, 2021
Is Multiple Myeloma a Greater Threat to Black Patients? Incidence and treatment disparities combined with a heightened COVID risk is cause for concern Nov 11, 2021
A Gentler Standard for Acute Promyelocytic Leukemia in Kids ATRA/arsenic trioxide without maintenance therapy resulted in 99-100% survival at 2 years Nov 11, 2021
Rare Case of Multiple Myeloma in Teenage Girl Successful use of affordable induction therapy with autologous stem cell transplantation Nov 09, 2021
Vaccinated Blood Cancer Patients Still at Risk for Severe COVID-19 Those with hematologic malignancies also remain at higher risk of mortality as well Nov 08, 2021
Investigational Oral CKD-Anemia Agent Effective, Safe HIF-PHI daprodustat increased hemoglobin without hurting heart Nov 05, 2021
Benzene Found in Spray Deodorants Now Too, Valisure Says Online pharmacy has previously petitioned FDA regarding contaminated hand sanitizers, sunscreens Nov 05, 2021
Ibrutinib Boosts Survival in Younger Patients With Certain DLBCL Subtypes New analysis "casts the PHOENIX trial in a new light," authors say Nov 04, 2021
Tumor Volume-Adapted RT Leads to Good Lung Cancer Control With Low Toxicity No recurrence at 1 year in 90% of cases with primary tumors, metastases, synchronous disease Nov 02, 2021
FDA Approves STAMP Inhibitor for Chronic Myeloid Leukemia Patients treated with two or more TKIs and those with T315I mutation gain new option Nov 01, 2021
Primary RT Fares Well in Abbreviated Trial for HPV Oropharyngeal Cancer No deaths, progression with RT after early termination because of deaths in surgery arm Oct 29, 2021
Pathologists Consider 'Workaround' So Patients Don't Freak Out Over EHR Bad News Doctors worry patients will misconstrue language or be psychologically harmed without guidance Oct 28, 2021
Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer No survival benefit, but risk of biochemical failure, metastasis, cancer death improved Oct 28, 2021
Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer Prolonged adjuvant ADT also improved survival Oct 27, 2021
Extended-Field RT Boosts Survival in Locally Advanced Cervical Cancer Double-digit improvements in OS, DFS, extrapelvic control in well-selected patients Oct 27, 2021
Gentler Adjuvant RT Could Be Viable for Some HPV-Positive Oral Cancers Those with extranodal extension didn't fare as well Oct 27, 2021
Gene Test Finds Gradations in High-Risk Prostate Cancer Study of untreated cancers prognostic for metastasis, cancer mortality, overall survival Oct 26, 2021
Low-Quality Mammography Leading to More Deaths in Black Women, Says Expert In cities like Chicago, Black women face higher breast cancer mortality versus white women Oct 26, 2021
No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer Women with medially or centrally located tumors may be candidates, however, says researcher Oct 26, 2021
Potential New Standard for Post-Prostatectomy Radiotherapy Side effects at 2 years similar with hypofractionated versus conventional RT Oct 25, 2021
Targeted RT Boosts PFS in Oligoprogressive Lung Cancer Fivefold improvement in NSCLC but no benefit in oligoprogressive breast cancer Oct 25, 2021
Two Mechanically Assisted Colonoscopy Devices Square Off Randomized trial revealed one found more and larger adenomas Oct 25, 2021
More Evidence for Safety of Accelerated Radiation in Early Breast Cancer Studies show low toxicity with few recurrences Oct 25, 2021
Cognitive Therapy Boosts Penile Injection Compliance Post-Prostatectomy Men became more comfortable with treatment to ward off ED, study suggests Oct 25, 2021
Benefits of Post-Op Penile Traction Therapy Hold Up Over Time Improvements in length, function seen at 9 months after prostatectomy Oct 23, 2021
Myeloma Drug Pulled From Market Just Months After Approval Data from confirmatory trial failed to make a compelling case for full FDA approval Oct 22, 2021
